Parabilis Medicines showcases FOG-001, a pioneering cancer therapy, at ESMO 2025, achieving significant tumor reductions in desmoid patients.

Results from a recent trial indicate promising outcomes for DATROWAY® in treating metastatic urothelial cancer, developed by Daiichi Sankyo and AstraZeneca.

BioTalent Canada has been recognized as a 2025 Employer of Choice by Canadian HR Reporter, highlighting its commitment to workplace excellence and inclusivity.

Wolters Kluwer Health presents cutting-edge AI solutions at HLTH 2025, enhancing clinical workflows and decision-making for healthcare professionals.

Despite regulatory reforms, Argentina's insurance industry is pressured by inflation and currency issues, complicating capital management for insurers.

Eaton Vance Short Duration Diversified Income Fund and Limited Duration Income Fund announce strategic changes to investment policies effective October 17, 2025.

Komaspec has launched a 60,000 sq ft manufacturing facility in Hai Phong, Vietnam, enhancing its global manufacturing capabilities and creating new jobs.

The National Duals Invitational, backed by Paycom, adds $50K in bonuses, enhancing the $1 million prize pool for teams competing in Tulsa on Nov. 15-16.

Seven Seas Water Group breaks ground on a new desalination plant in Aruba, enhancing water security and sustainability for the island's residents.

AM Best has affirmed the strong credit ratings of Constitution Insurance Company, highlighting its financial stability and strategic reinsurance agreements.

GSK has announced Beste Erkutay as the new Ethics and Compliance Leader for its operations in Turkey, enhancing its ethical standards in healthcare.

Travere Therapeutics will present 11 abstracts, including late-breaking data, at the ASN Kidney Week 2025 in Houston, highlighting FILSPARI® for kidney diseases.

WebBank has officially announced the appointment of Philip Gitler as Senior Vice President, overseeing the lender finance division and asset-backed lending growth.

AM Best confirms strong credit ratings for China Taiping Insurance (Singapore), indicating solid financial health and stable outlook amid market uncertainties.

Oregon Bancorp reveals a net income of $1.1 million for Q3 2025, showing resilience amid economic challenges while maintaining strong credit quality.

Diorasis Therapeutics announces the addition of Dr. Dimitri Azar to its Board, enhancing its expertise in ophthalmology and gene therapy development.

Turkcell's CEO, Ali Taha Koç, emphasizes local components for a secure 5G experience without compromising sustainability.